Sky State shares proposed to buy a U.S. bio-pharmaceutical companies

Every reporter Ma Yu fly support days State shares (002124, the former closing price of 14.78 yuan) recent stock prices soared "motive force" finally clear. The company announced today that the company recently and the United States United Biomedical Co., Ltd. (UBI) on equity investment and product cooperation between the exchange and negotiations, is intended to participate in 10 U.S. dollars per share of UBI common stock 2.5 million shares, the days of the total capital contribution of 25 million U.S. dollars, equity participation after the total number of UBI equity　　%, at the same time, UBI agreed to obtain a seat on the board. The bulletin shows that Ubi is a pharmaceutical enterprise that develops and manufactures diseases that are difficult to prevent and treat humans and animals. According to the memorandum signed by the two parties, UBI has granted exclusive license to the state stake in a specific range of foot-and-mouth disease vaccine, boar castration vaccine, porcine circovirus vaccine technology, expertise, products, patents obtained in various parts of China or patent applications, and its authorized areas are restricted to mainland China.　　Ubi shall be responsible for the effectiveness of the cooperative products, safety and technology research and development, at the same time to assist the days of the stock products before the listing of the test, product registration and other relevant technical documents preparation; The State shares shall be responsible for all necessary license and document numbers prior to the trial, listing and official sale of all authorized products prior to listing in China. Ubi and the Sky State shares agreed to the rights and profit sharing share of the way to reach a mandate.　　During the operating period according to different years, the two sides carry out different proportions of the rights and profit distribution ratio. However, the Sky state shares also said in the announcement that there is still a great deal of uncertainty between the two sides, the scope of product cooperation business involved in the products are not currently approved by the relevant Chinese government departments, and as of the announcement date, the company's due diligence on the UBI has not been formally launched,　　The company and Ubi did not sign a letter of intent or formal cooperation agreement on equity investment and product cooperation operation.　　On the other hand, the sky state shares also denied the company's wholly-owned subsidiary of Chengdu Tian Bang Biological Products Co., Ltd. application for the production of swine flu vaccine, and the company to buy the Vietnam gold mine rumors. In addition, the company's shares also revised the first half of this year's performance forecasts.　　According to previous forecasts, the company's January-June net profit fell 90%~95% Year-on-year, and the revised expected performance, January-June net profit of about 7 million yuan to 10 million yuan. The announcement shows that the shares of the Sky State shares will be a duplicate today.